Impact of the COVID-19 outbreak on cancer patient flow and management: experience from a large university hospital in Spain

by Luis Paz-Ares, Luis Manso, Guillermo De Velasco
Published 2020-05-01

KRAS oncogene in lung cancer: focus on molecularly driven clinical trials

by Emmanuelle Kempf, Benoît Rousseau, Benjamin Besse, Luis Paz-Ares
Published 2016-03-01

Corrigendum to “Tyrosine Kinase Receptor Landscape in Lung Cancer: Therapeutical Implications”

by A. Quintanal-Villalonga, Luis Paz-Ares, Irene Ferrer, S. Molina-Pinelo
Published 2018-01-01

Durvalumab in NSCLC: latest evidence and clinical potential

by Nerea Muñoz-Unceta, Isabel Burgueño, Elizabeth Jiménez, Luis Paz-Ares
Published 2018-10-01

Tyrosine Kinase Receptor Landscape in Lung Cancer: Therapeutical Implications

by A. Quintanal-Villalonga, Luis Paz-Ares, Irene Ferrer, S. Molina-Pinelo
Published 2016-01-01

Enhanced Cytotoxic Activity of Mitochondrial Mechanical Effectors in Human Lung Carcinoma H520 Cells: Pharmaceutical Implications for Cancer Therapy

by Sergio González Rubio, Sergio González Rubio, Nuria Montero Pastor, Nuria Montero Pastor, Carolina García, Víctor G. Almendro-Vedia, Víctor G. Almendro-Vedia, Irene Ferrer, Irene Ferrer, Paolo Natale, Paolo Natale, Luis Paz-Ares, Luis Paz-Ares, Luis Paz-Ares, Luis Paz-Ares, M. Pilar Lillo, Iván López-Montero, Iván López-Montero
Published 2018-11-01

Proteomic-Based Approaches for the Study of Cytokines in Lung Cancer

by Ángela Marrugal, Laura Ojeda, Luis Paz-Ares, Sonia Molina-Pinelo, Irene Ferrer
Published 2016-01-01

Corrigendum to “Proteomic-Based Approaches for the Study of Cytokines in Lung Cancer”

by Ángela Marrugal, Laura Ojeda, Luis Paz-Ares, Sonia Molina-Pinelo, Irene Ferrer
Published 2018-01-01

Treating -mutant NSCLC: latest evidence and clinical consequences

by Pilar Garrido, María Eugenia Olmedo, Ana Gómez, Luis Paz Ares, Fernando López-Ríos, Juan Manuel Rosa-Rosa, José Palacios
Published 2017-09-01

Impact of Heat Shock Protein 90 Inhibition on the Proteomic Profile of Lung Adenocarcinoma as Measured by Two-Dimensional Electrophoresis Coupled with Mass Spectrometry

by Ángela Marrugal, Irene Ferrer, Maria Dolores Pastor, Laura Ojeda, Álvaro Quintanal-Villalonga, Amancio Carnero, Sonia Molina-Pinelo, Luis Paz-Ares
Published 2019-07-01

Association between the miRNA Signatures in Plasma and Bronchoalveolar Fluid in Respiratory Pathologies

by Sonia Molina-Pinelo, Rocío Suárez, María Dolores Pastor, Ana Nogal, Eduardo Márquez-Martín, José Martín-Juan, Amancio Carnero, Luis Paz-Ares
Published 2012-01-01

Identification of Predictive Biomarkers of Response to HSP90 Inhibitors in Lung Adenocarcinoma

by Ángela Marrugal, Irene Ferrer, David Gómez-Sánchez, Álvaro Quintanal-Villalonga, María Dolores Pastor, Laura Ojeda, Luis Paz-Ares, Sonia Molina-Pinelo
Published 2021-03-01

MAP17 predicts sensitivity to platinum-based therapy, EGFR inhibitors and the proteasome inhibitor bortezomib in lung adenocarcinoma

by Irene Ferrer, Álvaro Quintanal-Villalonga, Sonia Molina-Pinelo, Jose Manuel Garcia-Heredia, Marco Perez, Rocío Suárez, Santiago Ponce-Aix, Luis Paz-Ares, Amancio Carnero
Published 2018-08-01

361 A randomised open-label phase I/II study adding ONCOS-102 to pemetrexed/cisplatin in patients with unresectable malignant pleural mesothelioma – 12 month analysis of biomarkers...

by Magnus Jaderberg, Victor Levitsky, Luis Paz-Ares, Lukasz Kuryk, Nicolas Isambert, Susana Cedres, Xavier Serres, Charles Ricordel, Santiago Ponce Aix, Anne-Sophie Moller, Sylvia Vetrhus
Published 2020-11-01

A comparison of EGFR mutation testing methods in lung carcinoma: direct sequencing, real-time PCR and immunohistochemistry.

by Bárbara Angulo, Esther Conde, Ana Suárez-Gauthier, Carlos Plaza, Rebeca Martínez, Pilar Redondo, Elisa Izquierdo, Belén Rubio-Viqueira, Luis Paz-Ares, Manuel Hidalgo, Fernando López-Ríos
Published 2012-01-01

Phase II Randomized Study of Plitidepsin (Aplidin), Alone or in Association with L-carnitine, in Patients with Unresectable Advanced Renal Cell Carcinoma

by Patrick Schöffski, Vincente Guillem, Margarita Garcia, Fernando Rivera, Josep Tabernero, Martin Cullell, Jose Antonio Lopez-Martin, Patricia Pollard, Herlinde Dumez, Xavier Garcia del Muro, Luis Paz-Ares
Published 2009-03-01

The Roles of Imprinted <i>SLC22A18 </i>and <i>SLC22A18AS </i>Gene Overexpression Caused by Promoter CpG Island Hypomethylation as Diagnostic and Prognostic Biomarkers for Non-Small...

by José Francisco Noguera-Uclés, Laura Boyero, Ana Salinas, Juan Antonio Cordero Varela, Johana Cristina Benedetti, Reyes Bernabé-Caro, Amparo Sánchez-Gastaldo, Miriam Alonso, Luis Paz-Ares, Sonia Molina-Pinelo
Published 2020-07-01

A phase 2 study of an oral mTORC1/mTORC2 kinase inhibitor (CC-223) for non-pancreatic neuroendocrine tumors with or without carcinoid symptoms.

by Edward Wolin, Alain Mita, Amit Mahipal, Tim Meyer, Johanna Bendell, John Nemunaitis, Pam N Munster, Luis Paz-Ares, Ellen H Filvaroff, Shaoyi Li, Kristen Hege, Hans de Haan, Monica Mita
Published 2019-01-01

Identification of Oxidative Stress Related Proteins as Biomarkers for Lung Cancer and Chronic Obstructive Pulmonary Disease in Bronchoalveolar Lavage

by Amancio Carnero, Amparo Sanchez-Gastaldo, Rocío García-Carbonero, Maria Dolores Mediano, Jose L. López-Campos, Beatriz Romero-Romero, Sonia Molina-Pinelo, Ricardo Meléndez, Ana Nogal, Maria Dolores Pastor, Luis Paz-Ares
Published 2013-02-01

Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection

by Rocio Garcia-Carbonero, Ramon Salazar, Ignacio Duran, Ignacio Osman-Garcia, Luis Paz-Ares, Juan M. Bozada, Valentina Boni, Christine Blanc, Len Seymour, John Beadle, Simon Alvis, Brian Champion, Emiliano Calvo, Kerry Fisher
Published 2017-09-01